PO-0737: Predictors of PSA relapse in patients with intermediate risk prostate cancer treated with SBRT. (April 2016) - Kole, T.; Guleria, S.; Koneru, H.; Obayomi-Davies, O.; Yung, T.; Lei, S.; Collins, B.; Suy, S.; Dritschilo, A.; Collins, S.